Patrick Nef

Chief Executive Officer at Transcure Bioservices SAS

Health Technology

Commercial Services

Profile

Patrick Nef is the founder and currently serves as the Chief Executive Officer of Transcure Bioservices SAS, a company he founded in 2012.
In 2005, he held the position of Chairman & Chief Executive Officer at Domain Therapeutics SA.

Patrick Nef active positions

Companies	Position	Start
Transcure Bioservices SAS Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France.	Chief Executive Officer	2011-12-31

All active positions of Patrick Nef

Former positions of Patrick Nef

Companies	Position	End
Domain Therapeutics SA Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France.	President	2005-01-01

See the detail of Patrick Nef's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Patrick Nef's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Domain Therapeutics SA Domain Therapeutics SA BiotechnologyHealth Technology Domain Therapeutics SA discovers and develops drug candidates targeting G-protein coupled receptors (GPCR) in all major therapeutic fields. The firm?s products include technologies, such as DTect-All and BioSens-All. Its services encompass allosteric modulators identification, biased ligands selection, orphan and historically intractable GPCRs address and high throughput screening campaign. The company was founded by Maurice Isra?l, Pierre Potier, Bernard Jacques Alex Gilly, Yves Dunant and Pascal Neuville in 2008 and is headquartered in Illkirch-Graffenstaden, France.	Health Technology
Transcure Bioservices SAS Transcure Bioservices SAS Miscellaneous Commercial ServicesCommercial Services Transcure Bioservices SAS provides research and development platforms service. It offer services to pharmaceutical, biotech, start-up, and academic researchers who need solutions for drug profiling and development. The company was founded on June 07, 2012 and is headquartered in Archamps, France.	Commercial Services